AllianceBernstein
ENFN

AllianceBernstein’s Enfusion, Inc. ENFN Stock Holding History

AllianceBernstein’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,600
Closed -$553K – 3363
2025
Q1 		$553K Buy
49,600
+8,860
+22% +$97.9K ﹤0.01% 2515
2024
Q4 		$420K Sell
40,740
-9,840
-19% -$95.1K ﹤0.01% 2717
2024
Q3 		$480K Hold
50,580
– – ﹤0.01% 2676
2024
Q2 		$431K Buy
50,580
+6,930
+16% +$63.4K ﹤0.01% 2745
2024
Q1 		$404K Hold
43,650
– – ﹤0.01% 2678
2023
Q4 		$423K Sell
43,650
-6,000
-12% -$56K ﹤0.01% 2690
2023
Q3 		$445K Hold
49,650
– – ﹤0.01% 2632
2023
Q2 		$557K Buy
49,650
+11,050
+29% +$98K ﹤0.01% 2577
2023
Q1 		$405K Sell
38,600
-1,046,459
-96% -$11.5M ﹤0.01% 2655
2022
Q4 		$10.5M Sell
1,085,059
-1,334,772
-55% -$15M ﹤0.01% 1074
2022
Q3 		$29.9M Sell
2,419,831
-73,529
-3% -$897K 0.01% 711
2022
Q2 		$25.5M Buy
2,493,360
+17,271
+0.7% +$191K 0.01% 782
2022
Q1 		$31.5M Buy
2,476,089
+149,602
+6% +$2.29M 0.01% 749
2021
Q4 		$48.7M Buy
+2,326,487
New +$47M 0.02% 628

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AllianceBernstein's ENFN Position: Q2 2025 in Review

AllianceBernstein sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 49,600 shares — an estimated $553K sold.

AllianceBernstein first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $48.7M in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • AllianceBernstein reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 49,600 Enfusion, Inc. shares in Q2 2025, an estimated $553K.
  • AllianceBernstein first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • AllianceBernstein's Enfusion, Inc. position peaked at $48.7M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.